This pharmaceutical company is a leading manufacturer known for its commitment to research and development (R&D) and innovative products. They specialize in a wide range of therapeutic areas, including gastroenterology, cardiovascular health, diabetes, oncology, pain management, and nephrology. Their product portfolio encompasses various dosage forms such as finished formulations, DC granules and pellets, APIs, and intermediates. The company holds multiple GMP certifications (EU GMP, WHO GMP, ISO) and boasts a global presence in over 50 nations across the EU, North America, and other regions. They are dedicated to producing high-quality, affordable medications accessible to patients worldwide.

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.